Breast Cancer Deubiquitinating Enzyme (DUB) Inhibitor Profiling: Fixed-cell GR measures of 21 breast cell lines to 32 small molecule perturbagens. Dataset 2 of 2: Calculated dose response metrics. - Dataset (ID:20351)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Treatment Duration | GR50 | GRmax | GR_AOC | GEC50 | GRinf | hGR |
---|---|---|---|---|---|---|---|---|
BT-549 | HY-17542 | 72 | 121.066157283 | 0.9061 | 0.0081 | 95.3962 | 0.2549 | 2.9917 |
HCC1500 | IU1 | 72 | inf | 0.6977 | 0.0082 | 0.0000 | 0.9531 | 0.0100 |
HCC1937 | IU1 | 72 | inf | 0.8662 | 0.0085 | 0.0000 | 0.9831 | 0.0100 |
MCF7 | Doxycycline | 72 | inf | 0.9910 | 0.0087 | 0.0000 | 0.9840 | 0.0100 |
MDA-MB-134-VI | LDN57444 | 72 | inf | 0.4981 | 0.0089 | 0.0000 | 0.9326 | 0.0100 |
MCF 10A | HY-17542 | 72 | 122.726417103 | 0.9130 | 0.0108 | 200.5533 | -1.0000 | 2.2369 |
Hs 578T | 5-(4-fluorophenyl)-3-hydroxy-4-(5-methyl-2-furoyl)-1-(3-pyridinylmethyl)-1,5-dihydro-2H-pyrrol-2-one | 72 | inf | 1.0210 | 0.0119 | 0.0000 | 0.9987 | 0.0100 |
MCF 10A | IU1 | 72 | inf | 0.9050 | 0.0119 | 30.9108 | 0.8598 | 1.4169 |
HCC1419 | STK547622 | 72 | inf | 1.0781 | 0.0128 | 0.0000 | 1.0000 | 0.0100 |
HCC1500 | z-VAE(OMe)-fmk | 72 | inf | 1.1021 | 0.0136 | 0.0000 | 1.0000 | 0.0100 |
HCC202 | SB1-F-22 | 72 | inf | 0.5140 | 0.0137 | 13.2393 | 0.5091 | 4.4104 |
PDX1258 | 5-(4-fluorophenyl)-3-hydroxy-4-(5-methyl-2-furoyl)-1-(3-pyridinylmethyl)-1,5-dihydro-2H-pyrrol-2-one | 72 | inf | 1.0981 | 0.0141 | 0.0000 | 0.9940 | 0.0100 |
HCC1806 | HY-17542 | 72 | inf | 0.9036 | 0.0149 | 0.0000 | 0.9763 | 0.0100 |
MCF 10A | 5-(4-fluorophenyl)-3-hydroxy-4-(5-methyl-2-furoyl)-1-(3-pyridinylmethyl)-1,5-dihydro-2H-pyrrol-2-one | 72 | 738.9217363 | 0.8943 | 0.0150 | 255.4365 | 0.3311 | 1.0216 |
Hs 578T | STK547622 | 72 | inf | 0.9647 | 0.0155 | 0.0000 | 0.9968 | 0.0100 |
HCC1500 | HY-17542 | 72 | 139.024096434 | 0.7326 | 0.0159 | 49.2255 | 0.4705 | 2.7249 |
HCC1954 | STK547622 | 72 | inf | 0.8996 | 0.0165 | 0.0000 | 0.9826 | 0.0100 |
Hs 578T | IU1 | 72 | 63.4449771188 | 0.6256 | 0.0170 | 49.9183 | 0.2532 | 2.9451 |
MDA-MB-361 | 5-(4-fluorophenyl)-3-hydroxy-4-(5-methyl-2-furoyl)-1-(3-pyridinylmethyl)-1,5-dihydro-2H-pyrrol-2-one | 72 | inf | 1.0999 | 0.0175 | 0.0000 | 1.0000 | 0.0100 |
Hs 578T | z-VAE(OMe)-fmk | 72 | inf | 0.9948 | 0.0176 | 0.0000 | 0.9832 | 0.0100 |
BT-549 | USP7-IN-1 | 72 | 94.531181628 | 0.8209 | 0.0177 | 166.1357 | -1.0000 | 1.9483 |
HCC1428 | HY-17542 | 72 | inf | 0.7557 | 0.0179 | 0.0000 | 0.9697 | 0.0100 |
CAMA-1 | HY-17542 | 72 | inf | 0.8374 | 0.0179 | 0.0000 | 0.9681 | 0.0100 |
T47D | STK547622 | 72 | inf | 0.9428 | 0.0182 | 0.0000 | 0.9914 | 0.0100 |
BT-549 | z-VAE(OMe)-fmk | 72 | inf | 0.9727 | 0.0182 | 0.0000 | 0.9828 | 0.0100 |